J. M. McCrodden

发表

The neurotoxicity of MPTP and the relevance to Parkinson's disease.

J. Sullivan, K. Tipton, J. M. McCrodden, 1990, Pharmacology & toxicology.

The interactions of milacemide with monoamine oxidase.

K. Tipton, M. Youdim, J. M. McCrodden, 1994, Biochemical pharmacology.

Monoamine oxidase inhibitors and the cheese effect

K. Tipton, J. M. McCrodden, Mary C. F. Anderson, 1993, Neurochemical Research.

Metabolism of monoamines in malignant hyperthermia-susceptible pigs.

K. Tipton, C. Fowler, A. M. Wheatley, 1982, British journal of anaesthesia.

Oxidation and enzyme-activated irreversible inhibition of rat liver monoamine oxidase-B by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

K. Tipton, M. Youdim, J. M. McCrodden, 1986, The Biochemical journal.

The involvement of intestinal monoamine oxidase in the transport and metabolism of tyramine.

K. Tipton, N. Kennedy, J. M. McCrodden, 1988, Journal of neural transmission. Supplementum.

The catalytic behaviour of monoamine oxidase.

K. Tipton, A. O'Carroll, J. M. McCrodden, 1987, Journal of neural transmission. Supplementum.

Inhibition of rat liver monoamine oxidase by α-methyl- and N-propargyl-amine derivatives

K. Tipton, M. Youdim, A. Kalir, 1982 .

Metabolic and nutritional aspects of the effects of ethanol.

K. Tipton, G. Henehan, J. M. McCrodden, 1983, Biochemical Society transactions.

Enzymological Aspects of the Actions of the Parkinsonism-Inducing Neurotoxin MPTP

J. Sullivan, K. Tipton, J. M. McCrodden, 1990 .

ISOENZYMES OF HUMAN LIVER ALCOHOL DEHYDROGENASE AND ALDEHYDE DEHYDROGENASE IN ALCOHOLIC AND NON-ALCOHOLIC SUBJECTS

K. Tipton, J. M. McCrodden, K. Ward, 1983 .

Determination of amines, amine metabolites and some amine metabolizing enzymes by high performance liquid chromatography.

J. Sullivan, K. Tipton, A. M. Wheatley, 1990, Biomedical chromatography : BMC.

Metabolic aspects of the behavior of MPTP and some analogues.

J. Sullivan, K. Tipton, J. M. McCrodden, 1993, Advances in neurology.

The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-(4-[(3-chlorophenyl)methoxy]phenyl)-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as competing reactions.

K. Tipton, M. Strolin Benedetti, C. Fowler, 1983, The Biochemical journal.